Clinical Trial Update: A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Endostar in combination with chemotherapy and IMRT for advanced nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: China Three Gorges University, Yichang, China | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED